These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25340330)

  • 21. Utility of right ventricular strain imaging in predicting pulmonary vascular resistance in patients with pulmonary hypertension.
    Naderi N; Ojaghi Haghighi Z; Amin A; Naghashzadeh F; Bakhshandeh H; Taghavi S; Maleki M
    Congest Heart Fail; 2013; 19(3):116-22. PubMed ID: 23121695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of inhaled nitric oxide on the pulmonary circulation of the neonatal pig.
    Nelin LD; Moshin J; Thomas CJ; Sasidharan P; Dawson CA
    Pediatr Res; 1994 Jan; 35(1):20-4. PubMed ID: 8134193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
    Douwes JM; Humpl T; Bonnet D; Beghetti M; Ivy DD; Berger RM;
    J Am Coll Cardiol; 2016 Mar; 67(11):1312-23. PubMed ID: 26988953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echocardiography based estimation of pulmonary vascular resistance in patients with pulmonary hypertension: a simultaneous Doppler echocardiography and cardiac catheterization study.
    Lindqvist P; Söderberg S; Gonzalez MC; Tossavainen E; Henein MY
    Eur J Echocardiogr; 2011 Dec; 12(12):961-6. PubMed ID: 22011836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia.
    Lyle MA; Fenstad ER; McGoon MD; Frantz RP; Krowka MJ; Kane GC; Swanson KL
    Chest; 2016 Feb; 149(2):362-371. PubMed ID: 26204445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
    Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
    Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
    D'Alto M; Badagliacca R; Argiento P; Romeo E; Farro A; Papa S; Sarubbi B; Russo MG; Vizza CD; Golino P; Naeije R
    Chest; 2020 Feb; 157(2):376-383. PubMed ID: 31563498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Load Adaptability in Patients With Pulmonary Arterial Hypertension.
    Amsallem M; Boulate D; Aymami M; Guihaire J; Selej M; Huo J; Denault AY; McConnell MV; Schnittger I; Fadel E; Mercier O; Zamanian RT; Haddad F
    Am J Cardiol; 2017 Sep; 120(5):874-882. PubMed ID: 28705377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation.
    Frostell CG; Blomqvist H; Hedenstierna G; Lundberg J; Zapol WM
    Anesthesiology; 1993 Mar; 78(3):427-35. PubMed ID: 8457043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria.
    Costa EL; Jardim C; Bogossian HB; Amato MB; Carvalho CR; Souza R
    Vascul Pharmacol; 2005 Sep; 43(3):143-7. PubMed ID: 16061423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary vascular response to exercise in symptomatic heart failure with reduced ejection fraction and pulmonary hypertension.
    Verbrugge FH; Dupont M; Bertrand PB; Nijst P; Grieten L; Dens J; Verhaert D; Janssens S; Tang WH; Mullens W
    Eur J Heart Fail; 2015 Mar; 17(3):320-8. PubMed ID: 25639263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension.
    Richter MJ; Hsu S; Yogeswaran A; Husain-Syed F; Vadász I; Ghofrani HA; Naeije R; Harth S; Grimminger F; Seeger W; Gall H; Tedford RJ; Tello K
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L715-L725. PubMed ID: 33655769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the echocardiographic assessment of pulmonary pressure using the tricuspid regurgitant signal-The "chin" vs the "beard".
    Kyranis SJ; Latona J; Platts D; Kelly N; Savage M; Brown M; Hamilton-Craig C; Scalia GM; Burstow D
    Echocardiography; 2018 Aug; 35(8):1085-1096. PubMed ID: 29676489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.
    Samokhin AO; Hsu S; Yu PB; Waxman AB; Alba GA; Wertheim BM; Hopkins CD; Bowman F; Channick RN; Nikolic I; Faria-Urbina M; Hassoun PM; Leopold JA; Tedford RJ; Ventetuolo CE; Leary PJ; Maron BA
    J Heart Lung Transplant; 2020 Apr; 39(4):289-299. PubMed ID: 31952977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).
    Suntharalingam J; Hughes RJ; Goldsmith K; Doughty N; George P; Toshner M; Sheares KK; Pepke-Zaba J
    Vascul Pharmacol; 2007 Jun; 46(6):449-55. PubMed ID: 17368113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
    Klinger JR; Thaker S; Houtchens J; Preston IR; Hill NS; Farber HW
    Chest; 2006 Feb; 129(2):417-425. PubMed ID: 16478861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.
    Pepke-Zaba J; Higenbottam TW; Dinh-Xuan AT; Stone D; Wallwork J
    Lancet; 1991 Nov; 338(8776):1173-4. PubMed ID: 1682593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can Inhaled Nitric Oxide Response Predict Tolerance to Therapies and Survival in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension?
    Krishtopaytis E; Ampnti SA; Obeidat M; Ramahi N; Lane J; Toth D; Paul D; Tonelli AR
    Am J Cardiol; 2023 Nov; 207():363-369. PubMed ID: 37778225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension.
    Selimovic N; Rundqvist B; Bergh CH; Andersson B; Petersson S; Johansson L; Bech-Hanssen O
    J Heart Lung Transplant; 2007 Sep; 26(9):927-34. PubMed ID: 17845932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.